Slide 1: Exchange filing cover letter
3rd February, 2023 The Manager - Listing The Manager - Listing The National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Plot No. C/1, G. Block Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Scrip Code: EMAMILTD Scrip Code: 53116
Slide 2: Q3 & 9MFY23 Performance Update
Q3 & 9MFY23 Performance Update 3rd February 2023
Slide 3: Q3 & 9MFY23 Revenue Growth
Q3 & 9MFY23 Revenue Growth Q3FY23 Growth (%) 9MFY23 Growth (%) Particulars Over PY 3 year CAGR Over PY 3 year CAGR • Domestic Business 1% 6% 4% 6% • International Business 7% 13% 20% 10% Consolidated Net Sales 2% 7% 6% 7% • Other Operating Income -29% -16% -14% -11% Total Revenues 1% 7% 6% 7% Heli
Slide 4: Modern Trade & eCommerce continue to perform well
Modern Trade & eCommerce continue to perform well Modern Trade E-Commerce Q3FY23 Growth Q3FY23 Salience Q3FY23 Growth Q3FY23 Salience 20% 10.5% (+200 bps) 45% 7.9% (+260 bps) 9MFY23 Growth 9MFY23 Salience 9MFY23 Growth 9MFY23 Salience 28% 9.3% (+210 bps) 51% 7.7% (+270 bps) Growth & salience to Dome
Slide 5: BoroPlus Range
BoroPlus Range ▹ Warmer winter across the country impacted sales during the quarter ▹ Sales declined by 3% in Q3; (Q3 - 3 year CAGR at 5%) ▸ Growth of 3% in 9MFY23; (9M - 3 year CAGR at 5%) ▹ New launches – BoroPlus Antiseptic Soap, BoroPlus Soft and BoroPlus Aloe Vera Gel scaling up well ▸ Launched
Slide 6: Healthcare Range
Healthcare Range ▹ Sales grew by 2% in Q3 ; (Q3 - 3 year CAGR at 8%) ▸ Sales corrected by 12% in 9MFY23; (9M - 3 year CAGR at 10%) ▹ Launched Streeshaktiprash & Sonaprash in Medico range ▹ D2C portal Zanducare growing steadily led by digital NPDs despite drop in demand for immunity products ▸ Launch
Slide 7: Pain Management Range
Pain Management Range ▹ Sales declined by 2% in Q3; (Q3 - 3 year CAGR at 6%) ▸ Correction of 15% in 9MFY23; (9M - 3 year CAGR at 7%) ▹ Trade initiatives - ▸ Zandu Balm 100 ml SKU listed and launched in MT & E-com ▸ Initiated Consumer offer (20% free) for Zandu Balm Ultra power ▹ New launch Zandu Fas
Slide 8: Kesh King Range, Navratna Range
Kesh King Range ▹ Sales declined by 1% in Q3; (Q3 - 3 year CAGR at 4%) ▸ Growth of 1% in 9MFY23; (9M - 3 year CAGR at 8%) ▹ New launch, Kesh King Onion range performed strongly ▹ Marketing initiatives ▸ ‘New Hair Growth’ visual representation Strengthened in TVC featuring Shilpa Shetty ▸ Kesh King s
Slide 9: Male Grooming Range, 7 Oils in One
Male Grooming Range ▹ Sales declined by 1% in Q3; However, 10% growth in 9MFY23 ▹ New TVC launched for Fair and Handsome Cream and Facewash in Q3 highlighting functional benefits 7 Oils in One ▹ Sales grew by 5% in Q3 and by 15% in 9MFY23 ▹ Campaign continued in HSM and WB market and also on OTT pla
Slide 10: Innovations fueling growth
Innovations fueling growth 4% Contribution of NPD’s to overall Domestic Business 9% Contribution of NPDs in Modern Trade 22% Contribution of NPDs in E Commerce (incl. Zanducare) Q3FY23 9
Slide 11: International Business
International Business International Business ▹ Sales grew by 7% in Q3 despite disruption in key markets Region wise sales salience ▸ Ukraine, Sri Lanka and Nepal facing geopolitical issues AFRICA & ▹ Growth of 20% in 9MFY23 OTHERS 10% ▹ Bangladesh, UAE and Russia performed well CIS 14% SAARC 38% 9M
Slide 12: Q3 & 9MFY23 Profitability (Consolidated)
Q3 & 9MFY23 Profitability (Consolidated) Q3FY23 9MFY23 Financials 3 yr ₹ in 3 yr ₹ in crore Growth Margins Growth Margins CAGR crore CAGR Revenues 983 1% 7% 2,570 6% 7% COGS 336 6% 9% 34.1% 893 14% 9% 34.8% Gross Profit 647 -1% 5% 65.9% 1,677 3% 5% 65.2% A&P Spends 153 -3% 3% 15.6% 431 15% 5% 16.8%
Slide 13: Q3FY23 Financial Analysis
Q3FY23 Financial Analysis A&P Costs Cost of Goods Sold Staff Costs (as a % of sales) (as a % of sales) (as a % of sales) +150 bps +200 bps -70 bps 9.5% 16.3% 15.6% 34.1% 7.5% 32.6% Q3FY22 Q3FY23 Q3FY22 Q3FY23 Q3FY22 Q3FY23 Admin & Other Exp Other Income Interest Paid (as a % of sales) (₹ in Millions
Slide 14: 9MFY23 Financial Analysis
9MFY23 Financial Analysis Staff Costs A&P Costs Cost of Goods Sold (as a % of sales) (as a % of sales) (as a % of sales) +80 bps +140 bps +230 bps 15.4% 16.8% 34.8% 32.5% 9.9% 10.7% 9MFY22 9MFY23 9MFY22 9MFY23 9MFY22 9MFY23 Admin & Other Exp Other Income Interest Paid (as a % of sales) (₹ in Million
Slide 15: Q3FY23 Consolidated Financials
Q3FY23 Consolidated Financials ₹ in Million Particulars Q3FY23 % Q3FY22 % Growth FY22 % Net Sales 9,750.9 99.2% 9,602.7 98.9% 1.5% 31,575.3 98.9% Other Operating Income 76.3 0.8% 107.9 1.1% -29.3% 345.0 1.1% Revenue from Operations 9,827.2 100.0% 9,710.6 100.0% 1.2% 31,920.3 100.0% Materials Cost 3,
Slide 16: 9MFY23 Consolidated Financials
9MFY23 Consolidated Financials ₹ in Million Particulars 9MFY23 % 9MFY22 % Growth FY22 % Net Sales 25,454.1 99.1% 23,908.2 98.8% 6.5% 31,575.3 98.9% Other Operating Income 243.7 0.9% 282.1 1.2% -13.6% 345.0 1.1% Revenue from Operations 25,697.8 100.0% 24,190.3 100.0% 6.2% 31,920.3 100.0% Materials Co
Slide 17: Awards, Accolades & Recognitions
Awards, Accolades & Recognitions Mr Harsha V. Agarwal, Vice Mr Prashant Goenka, Executive Chairman & Managing Director, Director, Emami Ltd. felicitated with the Emami Ltd, elected as Vice “Entrepreneur of the Year – 2022” President of Federation of Indian Award (Consumer Category) in Dubai by Chamb
Slide 18: Thank you
Thank you OC = a”